Eclevar has the expertise to proactively plan, manage and execute medical device studies of all sizes, in France and internationally.
We adapt our solutions to your challenges: our experts can help you identify countries, regions or continents for your study.
Our strong relationships with KOLs, clinical research sites and experienced consultants allow us to select the right sites worldwide.
The multicultural and multilingual nature of our staffs gives us a better understanding of the local cultural and regulatory environment.
Regulatory pathways and legislators differ around the globe: our teams can help you optimize your international strategy.
Teaming up with a global medical device CRO like Eclevar that is proficient in managing clinical research worldwide brings greater control over timelines and budget.
ECLEVAR FRANCE:
Tour Europlaza
20 avenue André Prothin
92 827 Paris La Défense Cedex
France
ECLEVAR UK Limited:
3rd Floor 207 Regent Street, London, W1B 3HH
ECLEVAR GMBH
ERFURT, Erfurt Hauptbahnhof
4th, 5th floor
Bahnhofstr. 38 Erfurt
99084
ECLEVAR Australia
Umina Beach NSW 2257, Australia
About Dr. Zeinab Darwich
Passionate about science, especially biology and the medical field, Zeinab worked for about 5 years after her PhD for public laboratories and then for Sanofi.
She obtained a PhD in biophysics and cell biology at the University of Strasbourg in 2012. For two years after, she worked as a post-doc at INRA in Dijon, followed by three years at Sanofi R&D as a research scientist, then as a biomarker manager for clinical trials until 2019.
In November 2020, she started to follow the DU FIEC (training of investigators in clinical trials) at the University of Paris to deepen her knowledge on clinical trials and advance in the medical field.
Throughout her professional experiences, she has developed a wide range of skills from writing of articles, protocols, reports, book chapters to technical skills in biophysics, cell biology, and immunohistochemistry. These experiences enabled her to develop soft skills such as team spirit, multitasking autonomy and project management.
About Dr. Dimithu Perrera
With an MSc in Molecular Medicine from the University of Essex and a BSc in Bioscience from Canterbury Christ Church University in the UK, Don is an experienced medical writer with a proven track record in a variety of therapeutic areas, including respiratory, gastroenterology, cancer, immunoassays and all classes of medical devices.
He has 5 years of experience in medical writing, including CERs and PERs, as well as 4 years in regulatory affairs.
Clinical studies are also an important part of his background. Don has conducted clinical studies around the world, working closely with KOLs, and has created and led a clinical board.
About Valérie Longin
Valérie holds a Master’s degree in Biotechnology R&D from the Pierre and Marie Curie University and started her career at Roche in pharmacovigilance.
She then headed to the field of clinical research as a CRA/TEC at URC Necker Cochin, then joined IQVIA as CRA for interventional studies and later as Lead CRA for real life studies in different therapeutic areas.
With nearly 10 years of experience in healthcare, Valérie brings to Eclevar her expertise in clinical research and her excellent relationship with the various stakeholders.
About Dr. Youssef El Dsouki
Graduated from the Pierre et Marie Curie (Paris VI) University in Circulation Extra Corporelle, Paris Descartes University in Healthcare Management and Université Paris-Sorbonne University in Extra corporeal circulation and circulatory support, he is an experienced European Board Certified Perfusionist (CCP) with a demonstrated leadership and history of working in hospitals & health care industry.
Skilled in Perfusion technology, Cardiothoracic Surgery, Clinical Research, Medical Education, and Medical Devices.
About Pr. Luc Téot
Pr. Luc Téot is the head of the Burns Unit and Wound Healing Unit of the Montpellier University Hospital in France. He is author of over 100 publications and wrote several books and book chapters.
He is an editorial board member of 8 journals and former president of the World Union of Wound Healing Societies and the European Tissue Repair Society.
He teaches as professor at the universities of Montpellier, Nantes, Limoges, Antilles and La Réunion. His passion for wound healing and scarring has encouraged him to become organiser of international conferences like Scar Club, Conférence de Plaies et Cicatrisation and the International Workshops on Wound Technology. Prof. Téot is qualified in General, Orthopaedic and Plastic surgery.
About Dr. Max Woitok
Dr. Max Woitok holds a degree in biology from the RWTH Aachen University and has a 10-year experience.
After his bachelor’s degree, he decided to focus on the biomedical research disciplines and proceeded with the master’s program in Biomedical Engineering at the RWTH Aachen University. The program was an interdisciplinary course of studies involving the interaction between the Natural Sciences, Medicine, and Engineering, providing him with theoretical and practical knowledge and methodic details in these subjects.
During the period of his master thesis, he was grateful to be accepted to work in the biomedical field at the Center for Biomedical Research, The Queen’s Medical Center in Honolulu, Hawai’i, U.S.A. After graduation, he took the opportunity to deepen his knowledge of biomedical engineering in the field of urology at the Uniklinik RWTH Aachen.
Next, he pursued a doctoral degree in the field of hepatocellular carcinoma at the clinic for Gastroenterology, Metabolic Diseases, and Internal Intensive Care Medicine, Uniklinik RWTH Aachen.
During his time as a Postdoc, he decided not to proceed with a scientific research career but to take the opportunity to work for a company located in Aachen, specialized in regulatory affairs for the medical device industry. This experience enabled him to gain deep insights in medical writing of clinical evaluations and Post-Market Clinical Follow-up (PMCF) studies under the new European Medical Device Regulation (MDR).
About Pr. Yann Gouëffic
Yann GOUËFFIC is the Head of Vascular Surgery Department at the Nantes CHU, the president of clinical trials department at Hospital of Saint Joseph.
He also is board member of the Meet congress as well as the head of Treasure of the French society of vascular and endovascular surgery.
He recently joined ECLEVAR as a scientific board member to help establish quality reimbursement routs (clinical and medico-economics data) is crucial to obtain the reimbursement and provide expertise in setting up clinical trials in France.
About Pr. Yann Gouëffic
Yann GOUËFFIC is the Head of Vascular Surgery Department at the Nantes CHU, the president of clinical trials department at Hospital of Saint Joseph.
He also is board member of the Meet congress as well as the head of Treasure of the French society of vascular and endovascular surgery.
He recently joined ECLEVAR as a scientific board member to help establish quality reimbursement routs (clinical and medico-economics data) is crucial to obtain the reimbursement and provide expertise in setting up clinical trials in France.
About Pr. Luc Téot
Pr. Luc Téot is the head of the Burns Unit and Wound Healing Unit of the Montpellier University Hospital in France. He is author of over 100 publications and wrote several books and book chapters.
He is an editorial board member of 8 journals and former president of the World Union of Wound Healing Societies and the European Tissue Repair Society.
He teaches as professor at the universities of Montpellier, Nantes, Limoges, Antilles and La Réunion. His passion for wound healing and scarring has encouraged him to become organiser of international conferences like Scar Club, Conférence de Plaies et Cicatrisation and the International Workshops on Wound Technology. Prof. Téot is qualified in General, Orthopaedic and Plastic surgery.
About Dr. Mikaela Dimitriu
A strategic growth-oriented executive with an extensive (over 25 years) of experience in management: clinical development, medical affairs, biometry, health economics, patient engagement, regulatory and manufacturing. A strong track in managing and leading cross-cultural and cross-functional global teams in complex situations.
She is recognized as an engaging, fast-moving, results-oriented leader with strong strategic thinking and execution skill from phase I to product launch; a distinct ability to generate a high-performance culture that attracts top talents and partners.
Mikaela has the ability to engage internal and external stakeholders in times of change and in challenging environments.
She has background training in science with extensive management experience at executive level. Specialties: Innovation (drug & medical device) – Oncology
Publications: 98 Abstracts, 77 posters and oral compiled for presentations at major international conferences in Europe and USA and articles in Cancer Research and Lancet Oncology
About Dr. Youssef El Dsouki
Graduated from the Pierre et Marie Curie (Paris VI) University in Circulation Extra Corporelle, Paris Descartes University in Healthcare Management and Université Paris-Sorbonne University in Extra corporeal circulation and circulatory support, he is an experienced European Board Certified Perfusionist (CCP) with a demonstrated leadership and history of working in hospitals & health care industry.
Skilled in Perfusion technology, Cardiothoracic Surgery, Clinical Research, Medical Education, and Medical Devices.
About Pr. Joaquim Alexandre
Pf. Joaquim Alexandre is Professor of Pharmacology since 2020 at Caen-Normandy University Hospital, France. He joins the Eclevar Scientific Board as referent in cardiology.
He joined the Caen-Normandy University Hospital in 2013 as a medical doctor in cardiology. He then became head of the clinical pharmacology unit in 2014, then adjunct head of the Clinical Research Center the following year. He became director of the cardio-oncology program in 2017.
Prof. Alexandre has over 90 publications to his credit, among them one on Cardiovascular immunotoxicities associated with immune checkpoint inhibitors published in the European Heart Journal in 2021 or Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors in the Lancet Haematologie.
About Pr. Joaquim Alexandre
Pf. Joaquim Alexandre is Professor of Pharmacology since 2020 at Caen-Normandy University Hospital, France. He joins the Eclevar Scientific Board as referent in cardiology.
He joined the Caen-Normandy University Hospital in 2013 as a medical doctor in cardiology. He then became head of the clinical pharmacology unit in 2014, then adjunct head of the Clinical Research Center the following year. He became director of the cardio-oncology program in 2017.
Prof. Alexandre has over 90 publications to his credit, among them one on Cardiovascular immunotoxicities associated with immune checkpoint inhibitors published in the European Heart Journal in 2021 or Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors in the Lancet Haematologie.
Camilla Fleetcroft
Camilla has a wealth of experience in both clinical and regulatory spaces. Since qualifying as a doctor, she has been working at the MHRA for over 8 years, with a period of time spent at SGS during this time as well. In her current role, she has been responsible for leading the consultation and development of the UK regulations for medical devices following Brexit, and is involved with policy makers, regularly interacting with ministers and decision makers.
Val Theisz
Val Theisz is a regulatory affairs professional with over 15 years of experience in medical devices of all risk classes, including life-sustaining, high-risk active implantables, and software as medical devices (SaMD) using Artificial Intelligence (AI) algorithms. Val holds Regulatory Affairs Certification credentials for EU and US regulations (RAC EU, RAC US) from the US-based Regulatory Affairs Professionals Society (RAPS and is one of the two RAPS Fellows based in Australia. She authored the book ‘Medical Device Regulatory Practices: An International Perspective’ available through CRC Press. Val’s experience within the field covers the entire product lifecycle: regulatory strategy; verification and validation (V&V); testing and compliance to international standards; clinical trials for high-risk innovative medical devices; submissions and pre-market approvals in established markets (CE Marking, FDA 510(k) and PMA, TGA registration, Health Canada licences); and post-market ongoing compliance. Her experience spans the major markets of the EU, USA, Australia and Canada. Val has also been the Director of Regulatory & Clinical Affairs, Code of Practice with the Medical Technology Association of Australia, leading industry advocacy initiatives with the Therapeutic Goods Administration and the Australian Department of Health.
Edmund White
A Medical Technology and Life Sciences products leader with over 20 years of progressive global, sales, marketing and operations experience and proven ability to consistently outperform expectations. Analyze markets, identify opportunities and create and implement strategies to achieve marketplace dominance. Develop relationships with key opinion leaders to influence potential customer perceptions. Entrepreneurial mindset with collaborative approach. Manage cross-functional teams and relationships with partners and affiliates worldwide